Want More Insights from FDA Matters? Check Out the Q&A Monday Tab for This Subscriber-First Feature

Short Takes and Updates
Written By STEVEN GROSSMAN

Every Monday, FDA Matters subscribers receive “Q&A Monday.” They may recirculate, quote from, or reprint it, etc., at their own discretion, which can be particularly useful for media. I do not publicly post the column until the following Monday. You can find past columns on the Q&A Monday tab (here).

If you would like to receive Q&A Monday columns every week “when-issued,” please subscribe on the site or email me at sgrossman@fdamatters.com. Here are two recent Q&A Monday columns:

Q&A - September 22, 2025 Read More

  • Is there something that received less attention but particularly concerns you? (Yes, termination of the Household Food Security survey)

  • Will there be a government shutdown? What are the likely impacts for FDA if there is one?

Q&A - September 8, 2025 Read More

  • Is Secretary Kennedy at risk of losing his job?

  • What is Kenvue? Doesn’t J&J make Tylenol?

  • How realistic is it to dramatically shorten product review cycles?

--------

The goal of FDA Matters is to analyze FDA policy and regulatory issues and advocate for a more effective, efficient, and fair FDA.

FDA Matters doesn't cover the news....we provide analysis of what's behind the news.

If you would like to subscribe (for free), you can do so on our website (www.fdamatters.com) or by sending a note to sgrossman@fdamatters.com. We recognize that you are busy, so we limit our content to 1-2 columns per week and ensure it is never more than a 3 to 5-minute read.

STEVEN GROSSMAN
Next

What to Expect When You Are Expecting a Shutdown--FDA Edition